

FTC, BIB, IRY, ONP Are Seasonally Ripe To Go Up In the Next Five Weeks
November 4, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of FstTr ET AlDex Shs Large Cap Growth AlphaDEX Fund (NASDAQ:FTC), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), SPDR S&P International Health Care Sector ETF (NYSE:IRY), Orient Paper Inc. (NYSE:ONP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Up:
Symbol Company Expected Return Odds By The Following Date FTC FstTr ET AlDex Shs Large Cap Growth AlphaDEX Fund 1.45% 88.89% (8 of 9) Monday, December 5th 2016 BIB ProShares Ultra Nasdaq Biotechnology 8.34% 100.00% (6 of 6) Wednesday, December 14th 2016 IRY SPDR S&P International Health Care Sector ETF 1.66% 85.71% (6 of 7) Monday, December 5th 2016 ONP Orient Paper Inc. 6.90% 85.71% (6 of 7) Tuesday, November 8th 2016FstTr ET AlDex Shs Large Cap Growth AlphaDEX Fund (NASDAQ:FTC) - The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Nasdaq AlphaDEX(R) Large Cap Growth Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is designed to select growth stocks from the NASDAQ US 500 Large Cap Index (the "base index") that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX(R) selection methodology..
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) - The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index . The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified..
SPDR S&P International Health Care Sector ETF (NYSE:IRY) - Spdr S&P International Health Care Sector.
Orient Paper Inc. (NYSE:ONP) - Orient Paper, Inc. produces and distributes paper products primarily in the People s Republic of China. The company offers corrugating medium paper used in the manufacture of cardboards; offset printing paper for the publishing industry; digital photo paper to advertising and printing companies for use in multiple-color printing; and local photo studios for the production of special event and personal home printouts. It also provides tissue paper products, including toilet papers, boxed and soft-packed tissues, handkerchief tissues, and paper napkins, as well as bathroom and kitchen paper towels under the Orient Paper brand name. Orient Paper, Inc. was founded in 1996 and is headquartered in Baoding, the People s Republic of China..
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net